ETORICOXIB 90mg. IP

A non-steroidal anti-inflammatory drug that minimizes inflammation and alleviates pain in arthritic and painful conditions. Eases pain and inflammation by blocking pain-causing enzymes cyclo-oxygenase-2. An alternative to other selective and traditional NSAIDs in treating patients with arthritis and other painful conditions. (Kubler, 2006) Demonstrates significantly greater benefit than diclofenac. (Kubler P. B., 2006) A long-acting analgesic with a rapid onset of action at 20–30 minutes. (Devalina Goswami, 2020) Provides a similar efficacy compared to the traditional NSAIDs (including naproxen, diclofenac, and ibuprofen) in pain, osteoarthritis, and rheumatic arthritis. (KUMARAVELU P, 2010) Produces good quality pain relief after acute postoperative pain in adults. (Devalina Goswami c. a., 2020) A safe, well-tolerated, and efficacious drug for the treatment of ankylosing spondylitis than naproxen. (Désirée van der Heijde 1, 2005) More effective than naproxen 500 mg for treating patients with rheumatoid arthritis over 12 weeks. (Alan K Matsumoto, 2002) Provides similar symptomatic relief to celecoxib in patients with osteoarthritis. (Katherine F Croom, 2009) Exhibits a greater selectivity for COX-2 over COX-1 compared with the COX-2 inhibitors rofecoxib, valdecoxib, and celecoxib. (Kubler, 2006) Displays significant improvements in the signs and symptoms of osteoarthritis of the knee.